Free Trial
→ How to claim a stake in SpaceX before the June 12 IPO (From Brownstone Research) (Ad)tc pixel Free LPCN Stock Alerts

Lipocine (LPCN) Short Interest Ratio & Short Volume

Lipocine logo
$1.98 -0.07 (-3.41%)
Closing price 04:00 PM Eastern
Extended Trading
$1.98 0.00 (-0.25%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Lipocine Short Interest Overview

As of May 29, 2026, Lipocine (LPCN) had a short interest of 90,238 shares sold short, representing 1.17% of the public float. This marks a -11.65% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.1, meaning it would take 1.1 days of the average trading volume of 283,925 shares to cover all short positions.

Current Short Interest
90,238 shares
Previous Short Interest
102,133 shares
Change Vs. Previous Month
-11.65%
Dollar Volume Sold Short
$203.04 thousand
Short Interest Ratio
1.1 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
8,240,000 shares
Short Percent of Float
1.17%
Today's Trading Volume
109,551 shares
Average Trading Volume
283,925 shares
Today's Volume Vs. Average
39%
Short Selling Lipocine?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lipocine and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LPCN Short Interest Over Time

LPCN Days to Cover Over Time

LPCN Percentage of Float Shorted Over Time

Lipocine Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202690,238 shares $203.04 thousand -11.7%1.2%1.08 $2.25
5/15/2026102,133 shares $230.82 thousand -41.2%1.3%0.98 $2.26
4/30/2026173,716 shares $404.76 thousand +12.7%2.2%0.64 $2.33
4/15/2026154,115 shares $394.53 thousand +7.3%2.3%0.09 $2.56
3/31/2026143,656 shares $1.15 million -5.7%2.1%1.62 $7.99
3/13/2026152,351 shares $1.12 million +8.0%2.2%1.23 $7.34
2/27/2026141,136 shares $1.41 million +11.3%2.7%1.12 $9.96
2/13/2026126,854 shares $1.10 million -1.0%2.4%2.4 $8.66
1/30/2026128,150 shares $1.15 million -12.4%2.5%0.99 $9.00
1/15/2026146,203 shares $1.65 million -7.2%2.8%0.62 $11.26
12/31/2025157,602 shares $1.27 million +41.9%3.0%0.67 $8.03
12/15/2025111,083 shares $349.91 thousand -3.6%2.1%5.99 $3.15
11/28/2025115,269 shares $363.10 thousand +0.3%2.2%1.39 $3.15
11/14/2025114,933 shares $329.86 thousand +8.1%2.3%4.04 $2.87
10/31/2025106,280 shares $282.70 thousand -2.5%2.1%2.44 $2.66
10/15/2025109,000 shares $338.99 thousand +0.3%2.1%3.5 $3.11
9/30/2025108,700 shares $309.80 thousand +33.4%2.1%3.3 $2.85
9/15/202581,500 shares $240.91 thousand -7.7%1.6%3.1 $2.96
8/31/202588,300 shares $256.95 thousand -5.1%1.7%2.3 $2.91
8/15/202593,000 shares $281.79 thousand -5.5%1.8%2.4 $3.03
7/31/202598,400 shares $317.83 thousand -2.0%1.9%1.8 $3.23
7/15/2025100,400 shares $301.20 thousand -10.8%1.9%1.9 $3.00
6/30/2025112,600 shares $355.82 thousand -6.9%2.2%2.4 $3.16
6/15/2025121,000 shares $377.52 thousand +25.7%2.3%2.9 $3.12
5/31/202596,300 shares $323.57 thousand +13.3%1.9%2.4 $3.36
5/15/202585,000 shares $317.05 thousand +20.4%1.6%2.9 $3.73
4/30/202570,600 shares $233.69 thousand -1.8%1.4%4.4 $3.31
4/15/202571,900 shares $219.30 thousand -5.9%1.4%3.8 $3.05
3/31/202576,400 shares $242.95 thousand -7.7%1.5%3.4 $3.18
3/15/202582,800 shares $277.38 thousand +8.7%1.6%3.1 $3.35
2/28/202576,200 shares $233.17 thousand +1.9%1.5%2.6 $3.06
2/15/202574,800 shares $271.52 thousand -3.7%1.4%2.4 $3.63
1/31/202577,700 shares $335.66 thousand +108.9%1.5%2.3 $4.32
1/15/202537,200 shares $171.86 thousand -23.3%0.7%1.2 $4.62
12/31/202448,500 shares $236.68 thousand -21.0%0.9%1.6 $4.88
12/15/202461,400 shares $308.23 thousand -0.8%1.2%2.2 $5.02
11/30/202461,900 shares $281.03 thousand +3.0%1.2%1.9 $4.54
11/15/202460,100 shares $293.89 thousand -20.1%1.2%2 $4.89
10/31/202475,200 shares $416.61 thousand -30.1%1.5%2.4 $5.54
10/15/2024107,500 shares $546.10 thousand -3.0%2.1%3.5 $5.08
SpaceX is offering you shares. Don't take them. (Ad)

SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required.tc pixel

Get the backdoor ticker free before the SpaceX IPO launches
9/30/2024110,800 shares $497.49 thousand -20.2%2.1%3.3 $4.49
9/15/2024138,800 shares $639.87 thousand +3.3%2.7%3.8 $4.61
8/31/2024134,400 shares $493.25 thousand -5.0%2.6%2.9 $3.67
8/15/2024141,400 shares $517.52 thousand +21.8%2.7%2.9 $3.66
7/31/2024116,100 shares $604.88 thousand -2.3%2.2%2.3 $5.21
7/15/2024118,800 shares $848.23 thousand -11.1%2.3%2.4 $7.14
6/30/2024133,700 shares $1.10 million -14.1%2.6%1.6 $8.24
6/15/2024155,600 shares $1.48 million -0.4%3.0%1.8 $9.49
5/31/2024156,200 shares $1.08 million -2.9%3.0%2.2 $6.92
5/15/2024160,800 shares $903.70 thousand -11.2%3.1%2.4 $5.62
4/30/2024181,000 shares $836.22 thousand -35.0%3.5%2.8 $4.62
4/15/2024278,400 shares $1.49 million +155.7%5.4%4.5 $5.36
3/31/2024108,900 shares $566.28 thousand -11.9%2.1%3.6 $5.20
3/15/2024123,600 shares $568.56 thousand +11.6%2.4%4.1 $4.60
2/29/2024110,800 shares $422.15 thousand -15.4%2.1%4.3 $3.81
2/15/2024131,000 shares $525.31 thousand -8.8%2.5%5.2 $4.01
1/31/2024143,600 shares $560.04 thousand +31.5%2.8%5.2 $3.90
1/15/2024109,200 shares $378.92 thousand -2.1%2.1%4 $3.47
12/31/2023111,500 shares $311.09 thousand -7.2%2.2%6.4 $2.79
12/15/2023120,100 shares $325.47 thousand -8.7%2.3%7.2 $2.71
11/30/2023131,600 shares $317.16 thousand -14.6%2.6%8.2 $2.41
11/15/2023154,100 shares $420.69 thousand +18.5%3.0%7.8 $2.73
10/31/2023130,000 shares $331.50 thousand -5.6%2.5%6.2 $2.55
10/15/2023137,700 shares $388.31 thousand -8.0%2.7%0.8 $2.82
9/30/2023149,700 shares $446.11 thousand +14.6%2.9%0.9 $2.98
9/15/2023130,600 shares $475.38 thousand +52.0%2.5%0.8 $3.64
8/31/202385,900 shares $339.31 thousand -12.3%1.7%0.5 $3.95
8/15/202397,900 shares $489.50 thousand -66.9%1.9%0.6 $5.00
7/31/2023296,100 shares $1.47 million +361.2%5.9%1.7 $4.97
7/15/202364,200 shares $277.34 thousand -22.0%1.3%2.5 $4.32
6/30/202382,300 shares $414.79 thousand +2.2%1.6%3.1 $5.04
6/15/202380,500 shares $412.97 thousand -25.8%1.6%3.1 $5.13
5/31/2023108,500 shares $502.36 thousand +35.5%2.1%3.9 $4.63
5/15/202380,100 shares $343.63 thousand +32.0%1.6%3.1 $4.29
4/30/20231,030,000 shares $267.80 thousand -7.2%1.2%5.3 $0.26
4/15/20231,110,000 shares $316.68 thousand -4.3%1.3%6.4 $0.29
3/31/20231,160,000 shares $369.00 thousand -7.9%1.4%6.7 $0.32
3/15/20231,260,000 shares $389.21 thousand -2.3%1.5%7.3 $0.31
2/28/20231,290,000 shares $582.18 thousand -6.5%1.5%10.7 $0.45
2/15/20231,380,000 shares $707.94 thousand -0.7%1.6%11.7 $0.51
1/31/20231,390,000 shares $736.70 thousand -2.8%1.6%10.3 $0.53
1/15/20231,430,000 shares $795.37 thousand -3.4%1.7%10 $0.56
12/30/20221,480,000 shares $588.74 thousand -1.3%1.7%11.1 $0.40
12/15/20221,500,000 shares $662.10 thousand -7.4%1.7%9.2 $0.44
11/30/20221,620,000 shares $729.16 thousand +3.9%1.9%8.7 $0.45
11/15/20221,560,000 shares $646.00 thousand -3.1%1.8%7.8 $0.41
10/31/20221,610,000 shares $658.49 thousand -2.4%1.9%6.6 $0.41
10/15/20221,650,000 shares $742.50 thousand No Change1.9%6.5 $0.45
9/30/20221,650,000 shares $742.50 thousand -13.6%1.9%6.5 $0.45
9/15/20221,910,000 shares $1.11 million +4.4%2.2%8 $0.58
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
8/31/20221,830,000 shares $1.06 million -5.7%2.1%8.2 $0.58
8/15/20221,940,000 shares $1.37 million -12.2%2.3%8.7 $0.70
7/31/20222,210,000 shares $1.67 million -1.8%N/A10.7 $0.75
7/15/20222,250,000 shares $1.78 million -6.3%N/A8.8 $0.79
6/30/20222,400,000 shares $1.92 million +2.6%N/A7.1 $0.80
6/15/20222,340,000 shares $1.88 million -2.5%N/A4 $0.80
5/31/20222,400,000 shares $1.95 million +16.5%2.8%3.3 $0.81
5/15/20222,060,000 shares $1.60 million -3.7%2.4%2.5 $0.78
4/30/20222,140,000 shares $1.89 million -2.3%2.5%2.5 $0.88
4/15/20222,190,000 shares $2.32 million -8.4%2.6%2.5 $1.06
3/31/20222,390,000 shares $3.27 million -9.5%2.8%2.9 $1.37
3/15/20222,640,000 shares $3.85 million -2.6%3.1%3.9 $1.46
2/28/20222,710,000 shares $3.33 million -1.5%3.2%4.8 $1.23
2/15/20222,750,000 shares $3.19 million -6.5%3.2%5.5 $1.16
1/31/20222,940,000 shares $3.00 million -12.5%3.4%5.6 $1.02
1/15/20223,360,000 shares $3.35 million -6.7%3.9%5.6 $1.00
12/31/20213,600,000 shares $3.57 million -2.4%4.2%6 $0.99
12/15/20213,690,000 shares $3.99 million -7.1%4.3%6.5 $1.08
11/30/20213,970,000 shares $4.37 million -4.6%4.6%6.4 $1.10
11/15/20214,160,000 shares $4.99 million +6.1%4.8%5.2 $1.20
10/29/20213,920,000 shares $4.08 million +2.1%4.6%4.7 $1.04
10/15/20213,840,000 shares $4.34 million -1.5%4.5%4.7 $1.13
9/30/20213,900,000 shares $4.25 million +3.7%4.5%4.4 $1.09
9/15/20213,760,000 shares $4.32 million +0.8%4.4%3.9 $1.15
8/31/20213,730,000 shares $4.89 million +0.8%4.3%3.7 $1.31
8/13/20213,700,000 shares $5.37 million +5.4%4.3%3.9 $1.45
7/30/20213,510,000 shares $4.63 million +0.3%4.1%3.3 $1.32
7/15/20213,500,000 shares $4.45 million +10.1%4.1%3.3 $1.27
6/30/20213,180,000 shares $4.45 million +7.1%3.7%3.1 $1.40
6/15/20212,970,000 shares $3.92 million +10.4%3.5%2.6 $1.32

LPCN Short Interest - Frequently Asked Questions

Short interest is the volume of Lipocine shares that have been sold short but have not yet been closed out or covered. As of May 29th, traders have sold 90,238 shares of LPCN short. 1.17% of Lipocine's shares are currently sold short. Learn More on Lipocine's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LPCN shares currently have a short interest ratio of 1.1. Learn More on Lipocine's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.17% of Lipocine's floating shares are currently sold short.

Lipocine saw a decline in short interest in May. As of May 29th, there was short interest totaling 90,238 shares, a decline of 11.6% from the previous total of 102,133 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.17% of Lipocine's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lipocine: XBiotech Inc. (0.86%), Citius Oncology, Inc. (0.75%), Pliant Therapeutics, Inc. (5.93%), BioHarvest Sciences Inc. (0.36%), Seres Therapeutics, Inc. (5.22%), BeyondSpring Inc. (7.61%), Cassava Sciences, Inc. (14.94%), Forum Markets, Inc (27.20%), OKYO Pharma Limited Sponsored ADR (0.52%), Alaunos Therapeutics, Inc. (0.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling LPCN is an investing strategy that aims to generate trading profit from Lipocine as its price is falling. LPCN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lipocine occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LPCN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LPCN, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LPCN:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:LPCN) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
No. You’re not imagining it…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Live demo of Elon Musk’s AI agent
Jeff Brown picked Nvidia in 2016 - it's up 25,155%. He recommended Bitcoin at $240 - it's up 31,219%. Now he's...
Brownstone Research | Sponsoredtc pixel
Why is Elon giving away money?
Elon Musk is offering a free cash bonus to people who sign up for his new bank - and the early adopters includ...
InvestorPlace | Sponsoredtc pixel
Important SpaceX PREDICTION
The biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian s...
Banyan Hill Publishing | Sponsoredtc pixel
He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...
The Oxford Club | Sponsoredtc pixel